42 results on '"Tang, W.H. Wilson"'
Search Results
2. Renal perturbations with sodium–glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction
3. Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure – insights from TRANSFORM‐HF.
4. Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: Mechanistic insights into sodium handling
5. Prognostic value of gut microbe‐generated metabolite phenylacetylglutamine in patients with heart failure.
6. The Utilization and Impact of Cardiovascular Specialists on Guideline‐Directed Medical Scores: An Analysis of a Diverse, Multi‐state, Electronic Health Record‐Based Registry
7. Sodium and potassium changes during decongestion with acetazolamide – a pre‐specified analysis from the ADVOR trial
8. Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion
9. Insufficient reduction in heart rate during hospitalization despite beta‐blocker treatment in acute decompensated heart failure: insights from the ASCEND‐HF trial
10. The effect of intravenous ferric carboxymaltose on right ventricular function – insights from the IRON‐CRT trial
11. Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology
12. Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia
13. Identifying sodium non‐excretors : heart failure's emerging golden ticket for risk stratification
14. Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment
15. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study
16. Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure
17. Revisiting the cardio-renal hypothesis: the pivotal role of the kidney in congestive heart failure
18. A means to an end: the promise of tracking natriuresis with diuretic therapy
19. Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA‐HF trial
20. Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology
21. Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia.
22. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning‐based unsupervised cluster analysis
23. Can saline repletion be the true TARGET for achieving fluid balance in acute heart failure?
24. Temporal association between hospitalization event and subsequent risk of mortality among patients with stable chronic heart failure with preserved ejection fraction: insights from the TOPCAT trial
25. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT
26. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology
27. Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA-HF trial.
28. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis.
29. Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT
30. I will take my heart failure ‘lactate‐free’ please
31. Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF
32. Inflammation and cardio-renal interactions in heart failure: a potential role for interleukin-6
33. High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure
34. Insufficient reduction in heart rate during hospitalization despite beta‐blocker treatment in acute decompensated heart failure: insights from the ASCEND‐HF trial
35. Endothelin-1 is independently associated with 180-day mortality after adjusting for body mass index
36. Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure
37. Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure
38. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF
39. The kidney in congestive heart failure: ‘are natriuresis, sodium, and diuretics really the good, the bad and the ugly?’
40. Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians
41. The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'.
42. Non‐invasive prediction of pulmonary vascular disease‐related exercise intolerance and survival in non‐group 1 pulmonary hypertension.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.